000 | 01858 a2200541 4500 | ||
---|---|---|---|
005 | 20250517014804.0 | ||
264 | 0 | _c20160208 | |
008 | 201602s 0 0 eng d | ||
022 | _a1532-3064 | ||
024 | 7 |
_a10.1016/j.rmed.2014.12.010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSun, Hong | |
245 | 0 | 0 |
_aEffects of suvorexant, an orexin receptor antagonist, on breathing during sleep in patients with chronic obstructive pulmonary disease. _h[electronic resource] |
260 |
_bRespiratory medicine _cMar 2015 |
||
300 |
_a416-26 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAzepines _xtherapeutic use |
650 | 0 | 4 | _aCross-Over Studies |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOrexin Receptor Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
650 | 0 | 4 |
_aRespiration _xdrug effects |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aSleep _xdrug effects |
650 | 0 | 4 |
_aSleep Aids, Pharmaceutical _xtherapeutic use |
650 | 0 | 4 | _aSpirometry |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTriazoles _xtherapeutic use |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aPalcza, John | |
700 | 1 | _aRosenberg, Russell | |
700 | 1 | _aKryger, Meir | |
700 | 1 | _aSiringhaus, Tara | |
700 | 1 | _aRowe, Janice | |
700 | 1 | _aLines, Christopher | |
700 | 1 | _aWagner, John A | |
700 | 1 | _aTroyer, Matthew D | |
773 | 0 |
_tRespiratory medicine _gvol. 109 _gno. 3 _gp. 416-26 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.rmed.2014.12.010 _zAvailable from publisher's website |
999 |
_c24603797 _d24603797 |